Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 5:00 pm Purchase | 13G | PROQR THERAPEUTICS N.V. PRQR | Stichting Aescap Life Sciences | 5,406,159 7.6% | 578,787 (+11.99%) | View |
| 2022-02-04 4:58 pm Purchase | 13G | PROQR THERAPEUTICS N.V. PRQR | Stichting Aescap Life Sciences | 4,827,372 6.8% | 1,623,176 (+50.66%) | View |
| 2021-02-09 5:01 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES CORP AGTC | Stichting Aescap Life Sciences | 17,999 0.1% | -1,787,762 (-99.00%) | View |
| 2021-02-09 5:00 pm Purchase | 13G | PROQR THERAPEUTICS N.V. PRQR | Stichting Aescap Life Sciences | 3,204,196 6.4% | 3,204,196 (New Position) | View |
| 2020-01-27 5:20 pm Sale | 13G | APPLIED GENETIC TECHNOLOGIES CORP AGTC | Stichting Aescap Life Sciences | 1,805,761 9.9% | -81,162 (-4.30%) | View |
| 2019-11-21 4:10 pm Purchase | 13G | APPLIED GENETIC TECHNOLOGIES CORP AGTC | Stichting Aescap Life Sciences | 1,886,923 10.4% | 563,308 (+42.56%) | View |